Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/19/2012US20120184580 Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods of use thereof
07/19/2012US20120184579 Quinolines and Their Therapeutic Use
07/19/2012US20120184578 Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance
07/19/2012US20120184577 PI3 KINASE/mTOR DUAL INHIBITOR
07/19/2012US20120184576 Antipsychotic agents and standardized antipsychotic fractions from rauwolfia tetraphylla and process of their isolation
07/19/2012US20120184575 Topical administration carrier composition and therapeutic formulations comprising same
07/19/2012US20120184574 Indole derivatives and methods for antiviral treatment
07/19/2012US20120184573 process for the preparation of ambrisentan and novel intermediates thereof
07/19/2012US20120184572 Aryl gpr119 agonists and uses thereof
07/19/2012US20120184571 Quinazolinone derivatives useful as vanilloid antagonists
07/19/2012US20120184570 Theophylline Derivative Inhibits Osteoporosis
07/19/2012US20120184569 A3 adenosine receptor agonists and antagonists
07/19/2012US20120184568 Processes for preparing isoquinolinones and solid forms of isoquinolinones
07/19/2012US20120184567 Inhibitors of bruton's tyrosine kinase
07/19/2012US20120184566 Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof
07/19/2012US20120184565 Compounds for the reduction of beta-amyloid production
07/19/2012US20120184564 Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
07/19/2012US20120184563 Composition for external application comprising aripiprazole and organic acid as active ingredients
07/19/2012US20120184562 1,6- and 1,8-naphthyridines
07/19/2012US20120184561 Phenylacetamides suitable as protein kinase inhibitors
07/19/2012US20120184560 Molecular diagnostic methods for predicting brain metastasis of breast cancer
07/19/2012US20120184559 Novel compounds that are useful for improving pharmacokinetics
07/19/2012US20120184558 Crystalline Salt Forms of a 5,6,7,8-Tetrahydro-1,2,4-Triazolo[4,3-a]Pyrazine Derivative
07/19/2012US20120184557 Pyrazolo[1,5-a]-1,3,5-triazine derivatives, preparation thereof, and therapeutic use thereof
07/19/2012US20120184556 Substituted enzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators
07/19/2012US20120184554 Therapeutic agent for mood disorders
07/19/2012US20120184553 Novel compounds
07/19/2012US20120184552 Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin
07/19/2012US20120184551 Combination of brimonidine and timolol for topical ophthalmic use
07/19/2012US20120184550 Substituted nicotinamides as kcnq2/3 modulators
07/19/2012US20120184549 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
07/19/2012US20120184548 Carboxylic acid aryl amides
07/19/2012US20120184547 Methods for treating schizophrenia
07/19/2012US20120184546 [1,2,4]triazolo [1,5-c]pyrimidine derivatives as hsp90 modulators
07/19/2012US20120184545 Heart-slowing drug containing short-acting beta-blocker as teh active ingredient
07/19/2012US20120184544 Substituted benzamide derivatives as glucokinase (gk) activators
07/19/2012US20120184543 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof
07/19/2012US20120184542 Pyrido pyrimidines
07/19/2012US20120184541 Compounds and methods of use
07/19/2012US20120184540 1,4 oxazines as bace1 and/or bace2 inhibitors
07/19/2012US20120184539 Novel Heterocyclic Derivatives and Their Use in the Treatment of Neurological Disorders
07/19/2012US20120184538 Isoxazolo-pyridine derivatives
07/19/2012US20120184537 [1,4]-benzodiazepines as vasopressin v2 receptor antagonists
07/19/2012US20120184536 Compositions comprising specific ugt inhibitors and methods of use thereof
07/19/2012US20120184535 Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
07/19/2012US20120184534 Tri-cyclic pyrazolopyridine kinase inhibitors
07/19/2012US20120184533 Small molecule inhibitors of parp activity
07/19/2012US20120184532 Galantamine amino acid and peptide prodrugs and uses thereof
07/19/2012US20120184531 BENZOFURO[3,2-c] PYRIDINES AND RELATED ANALOGS AS SEROTONIN SUB-TYPE 6 (5-HT6) MODULATORS FOR THE TREATMENT OF OBESITY, METABOLIC SYNDROME, COGNITION AND SCHIZOPHRENIA
07/19/2012US20120184530 Dimeric IAP Inhibitors
07/19/2012US20120184529 Combination therapy
07/19/2012US20120184528 7-ARYL-1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
07/19/2012US20120184527 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
07/19/2012US20120184526 Compounds and compositions as syk kinase inhibitors
07/19/2012US20120184525 1,2,3-triazolo [4,3-a] pyridine derivatives and thier use for the treatment of prevention of neurological and psychiatric disorders
07/19/2012US20120184524 Pyrazolopyridine kinase inhibitors
07/19/2012US20120184523 C-Met Modulators and Method of Use
07/19/2012US20120184522 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
07/19/2012US20120184521 Substituted amide compound
07/19/2012US20120184520 Glycine compound
07/19/2012US20120184519 Compositions and Methods for Preventing or Treating Influenza Virus Infection
07/19/2012US20120184518 Methods of treating or preventing an inflammatory disease or condition using glutaminyl cyclase inhibitors
07/19/2012US20120184517 Treatment of diseases with altered smooth muscle contractility
07/19/2012US20120184516 sGC Stimulators
07/19/2012US20120184515 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases
07/19/2012US20120184514 Vitamin d compounds and methods for preparing same
07/19/2012US20120184512 Gyrase and topoisomerase iv inhibitors
07/19/2012US20120184511 Novel Pharmaceutical Composition Comprising a Macrolide Immunosuppressant Drug
07/19/2012US20120184510 Cold menthol receptor-1 antagonists
07/19/2012US20120184509 Compounds as TRVP1 Blockers, Pharmaceutical Compositions and Medical Uses Thereof
07/19/2012US20120184508 Pyrazolo pyrimidines
07/19/2012US20120184507 Leaven-based mixture
07/19/2012US20120184506 Use of sulfated oligosaccharides as slimming cosmetic ingredients
07/19/2012US20120184505 Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
07/19/2012US20120184504 "The Use of a PAR-1 Antagonist in Combination with a P2Y12 ADP Receptor Antagonist for Inhibition of Thrombosis"
07/19/2012US20120184503 Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
07/19/2012US20120184502 Optimised formulation of tobramycin for aerosolization
07/19/2012US20120184501 Antibacterial aminoglycoside analogs
07/19/2012US20120184500 Stevia extract or steviol for hair care
07/19/2012US20120184499 Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
07/19/2012US20120184498 Dermaseptin b2 used as an inhibitor of the growth of a tumor
07/19/2012US20120184496 Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
07/19/2012US20120184495 Targeted nano-photomedicines for photodynamic therapy of cancer
07/19/2012US20120184494 Multiple myeloma prognosis and treatment
07/19/2012US20120184493 Dermal formulations of dp2 receptor antagonists
07/19/2012US20120184492 Therapeutic use of a growth factor, nsg33
07/19/2012US20120184486 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
07/19/2012US20120184014 Photoactive Metal Nitrosyls for Blood Pressure Regulation and Cancer Therapy
07/19/2012US20120183634 Synergistic Compositions That Treat or Inhibit Pathological Conditions Associated With Inflammatory Response
07/19/2012US20120183632 Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
07/19/2012US20120183630 Compositions and methods for stimulating wound healing
07/19/2012US20120183629 Low viscosity liquid polymeric delivery system
07/19/2012US20120183627 Compositions for the treatment of hemorrhoids and related diseases
07/19/2012US20120183621 Synergistic combinations to reduce particle dose for targeted treatment of cancer and its metastases
07/19/2012US20120183618 Modular systems for the controlled release of a substance with space and time control
07/19/2012US20120183617 Composition and method for treatment of diabetes
07/19/2012US20120183615 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone
07/19/2012US20120183614 Polyphenol compound absorption promoter and utilization of same
07/19/2012US20120183613 Novel Pharmaceutical Composition
07/19/2012US20120183612 Matrix for sustained, invariant and independent release of active compounds
1 ... 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 ... 7860